Impact of radiocontrast use during left ventricular pacemaker lead implantation for cardiac resynchronization therapy

Europace

Volumn 14, Issue 2, 2012, Pages 243-248

  Tester, Gregory A ^a   Noheria, Amit ^b   Carrico, Heather L ^a   Mears, Jennifer A ^a   Cha, Yong Mei ^a   Powell, Brian D ^a   Friedman, Paul A ^a   Rea, Robert F ^a   Hayes, David L ^a   Asirvatham, Samuel J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy (CRT); Contrast induced nephropathy; Device implantation; LV lead; Radiocontrast

Indexed keywords

CONTRAST MEDIUM; CREATININE;

ADULT; ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FLUOROSCOPY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CONTRAST MEDIA; DRUG TOXICITY; ELECTRODES, IMPLANTED; FEMALE; HEART VENTRICLES; HUMANS; KIDNEY DISEASES; MALE; MINNESOTA; PREVALENCE; PROSTHESIS IMPLANTATION; RISK ASSESSMENT; RISK FACTORS; SURGERY, COMPUTER-ASSISTED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84856305041     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur282     Document Type: Review

References (26)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 2011; 121: 948-54.
2. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 focused update of esc guidelines on device therapy in heart failure: An update of the 2008 esc guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 esc guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the heart failure association and the european heart rhythm association. Europace 2010; 12: 1526-36.
3. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-38.
4. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: A systematic review. JAMA 2007; 297: 2502-14. (Pubitemid 46953404)
5. Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (madit-crt) trial. Circulation 2011; 123: 1159-66.
6. Helm RH, Byrne M, Helm PA, Daya SK, Osman NF, Tunin R et al. Threedimensional mapping of optimal left ventricular pacing site for cardiac resynchronization. Circulation 2007; 115: 953-61. (Pubitemid 46328288)
7. Rossillo A, Verma A, Saad EB, Corrado A, Gasparini G, Marrouche NF et al. Impact of coronary sinus lead position on biventricular pacing: mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol 2004; 15: 1120-5. (Pubitemid 39426037)
8. Wilton SB, Shibata MA, Sondergaard R, Cowan K, Semeniuk L, Exner DV. Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol 2008; 23: 219-27.
9. Asirvatham SJ. Cardiac resynchronization: is electrical synchrony relevant? J Cardiovasc Electrophysiol 2007; 18: 1028-31. (Pubitemid 47416577)
10. Habib A, Lachman N, Christensen KN, Asirvatham SJ. The anatomy of the coronary sinus venous system for the cardiac electrophysiologist. Europace. 2009; 11(Suppl 5): v15-21.
11. Asirvatham S. Anatomy of the coronary sinus. In: Yu CM HD, Auricchio, ed. Cardiac resynchronization therapy. Oxford: Blackwell/Futura; 2006. p. 211-238.
12. Lachman N, Syed FF, Habib A, Kapa S, Bisco SE, Venkatachalam KL et al. Correlative anatomy for the electrophysiologist, part I: the pericardial space, oblique sinus, transverse sinus. J Cardiovasc Electrophysiol 2010; 21: 1421-6.
13. Lachman N, Syed FF, Habib A, Kapa S, Bisco SE, Venkatachalam KL et al. Correlative anatomy for the electrophysiologist, part ii: cardiac ganglia, phrenic nerve, coronary venous system. J Cardiovasc Electrophysiol 2011; 22: 104-10.
14. Asirvatham S. Implanting a left ventricular pacemaker lead. Indian Heart J 2007; 59: 197-204.
15. Asirvatham S, Narayan O. Advanced catheter mapping and navigation system. In: Huang S, Wood M, eds. Catheter ablation of cardiac arrhythmias. Philidelphia: Saunders/ Elsevier; 2006. p. 135-161.
16. Hayes D, Wang P, Sackner-Bernstein J, Asirvatham S. Future of cardiac resynchronization. In: Hayes DL Ea, ed. Resynchronization and Defibrillation for Heart Failure a Practical Approach. Oxford: Blackwell/Futura; 2004.
17. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008; 51: 1419-28. (Pubitemid 351471786)
18. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259-64. (Pubitemid 34535335)
19. The criteria committee of the new york heart association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass.: Little, Brown & Co; 1994. p. 253-55.
20. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the modification of diet in renal disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004; 44: 84-93. (Pubitemid 38880931)
21. Levey A, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. Am Soc Nephrol 2000; 11: 155A.
22. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 2006; 98: 27K-36K.
23. Rosenstock JL, Gilles E, Geller AB, Panagopoulos G, Mathew S, Malieckal D et al. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 2010; 42: 1049-54.
24. From AM, Bartholmai BJ, Williams AW, Cha SS, McDonald FS. Mortality associated with nephropathy after radiographic contrast exposure. Mayo Clin Proc 2008; 83: 1095-1100.
25. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. J Am Coll Cardiol 2004; 44: 1393-99. (Pubitemid 39303939)
26. Asirvatham S. Biventricular device implantation. In: Hayes D, ed. Resynchronization and Defibrillation for Heart Failure: A Practical Approach. Oxford: Blackwell/Futura; 2004. p. 99-137.